Literature DB >> 26088524

Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?

Katharina Brandl1, Bernd Schnabl.   

Abstract

Changes in the intestinal microbiota composition contribute to the pathogenesis of many disorders including gastrointestinal and liver diseases. Recent studies have broadened our understanding of the "gut-liver" axis. Dietary changes, other environmental and genetic factors can lead to alterations in the microbiota. Dysbiosis can further disrupt the integrity of the intestinal barrier leading to pathological bacterial translocation and the initiation of an inflammatory response in the liver. In this article, the authors dissect the different steps involved in disease pathogenesis to further refine approaches for the medical management of liver diseases. The authors will specifically discuss the role of dysbiosis in inducing intestinal inflammation and increasing intestinal permeability.

Entities:  

Keywords:  bacterial translocation; gut-liver axis; intestinal barrier; intestinal inflammation; metabolome; metagenome; microbiome

Mesh:

Year:  2015        PMID: 26088524      PMCID: PMC4828034          DOI: 10.1586/17474124.2015.1057122

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  78 in total

Review 1.  Pathological bacterial translocation in liver cirrhosis.

Authors:  Reiner Wiest; Melissa Lawson; Markus Geuking
Journal:  J Hepatol       Date:  2013-08-28       Impact factor: 25.083

2.  Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice.

Authors:  Magdalena Mazagova; Lirui Wang; Andrew T Anfora; Max Wissmueller; Scott A Lesley; Yukiko Miyamoto; Lars Eckmann; Suraj Dhungana; Wimal Pathmasiri; Susan Sumner; Caroline Westwater; David A Brenner; Bernd Schnabl
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

3.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.

Authors:  Maria Van der Sluis; Barbara A E De Koning; Adrianus C J M De Bruijn; Anna Velcich; Jules P P Meijerink; Johannes B Van Goudoever; Hans A Büller; Jan Dekker; Isabelle Van Seuningen; Ingrid B Renes; Alexandra W C Einerhand
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

4.  Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease.

Authors:  Stephanie A Blair; Sunanda V Kane; Daniel R Clayburgh; Jerrold R Turner
Journal:  Lab Invest       Date:  2006-02       Impact factor: 5.662

Review 5.  Liver abnormalities in bowel diseases.

Authors:  Martin Kummen; Erik Schrumpf; Kirsten Muri Boberg
Journal:  Best Pract Res Clin Gastroenterol       Date:  2013-08       Impact factor: 3.043

6.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

7.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

Authors:  Lauren A Zenewicz; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Sean Stevens; Richard A Flavell
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

8.  Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study.

Authors:  Irina A Kirpich; Natalia V Solovieva; Svetlana N Leikhter; Natalia A Shidakova; Oxsana V Lebedeva; Pavel I Sidorov; Tatjana A Bazhukova; Andrej G Soloviev; Shirish S Barve; Craig J McClain; Matt Cave
Journal:  Alcohol       Date:  2008-12       Impact factor: 2.405

9.  Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity.

Authors:  Sophie Leclercq; Sébastien Matamoros; Patrice D Cani; Audrey M Neyrinck; François Jamar; Peter Stärkel; Karen Windey; Valentina Tremaroli; Fredrik Bäckhed; Kristin Verbeke; Philippe de Timary; Nathalie M Delzenne
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

10.  Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics.

Authors:  Sari Tuomisto; Tanja Pessi; Pekka Collin; Risto Vuento; Janne Aittoniemi; Pekka J Karhunen
Journal:  BMC Gastroenterol       Date:  2014-02-24       Impact factor: 3.067

View more
  16 in total

1.  Intestinal and hepatic microbiota changes associated with chronic ethanol administration in mice.

Authors:  Sena Bluemel; Lirui Wang; Claire Kuelbs; Kelvin Moncera; Manolito Torralba; Harinder Singh; Derrick E Fouts; Bernd Schnabl
Journal:  Gut Microbes       Date:  2019-04-14

Review 2.  The human gut microbiota: Metabolism and perspective in obesity.

Authors:  Aline Corado Gomes; Christian Hoffmann; João Felipe Mota
Journal:  Gut Microbes       Date:  2018-05-24

Review 3.  Disruption of the epithelial barrier during intestinal inflammation: Quest for new molecules and mechanisms.

Authors:  Susana Lechuga; Andrei I Ivanov
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-03-18       Impact factor: 4.739

4.  Effects of the Long-term Treatment of Proton Pump Inhibitors on the Function of Kidney and Liver in Laboratory Female Rats.

Authors:  S M J Al-Hadrawy; Z S Mahdi Al-Turfi
Journal:  Arch Razi Inst       Date:  2021-10-31

5.  Low potassium disrupt intestinal barrier and result in bacterial translocation.

Authors:  Haishan Wu; Rong Huang; Jinjin Fan; Ning Luo; Xiao Yang
Journal:  J Transl Med       Date:  2022-07-06       Impact factor: 8.440

6.  The Zonulin-transgenic mouse displays behavioral alterations ameliorated via depletion of the gut microbiota.

Authors:  Alba Miranda-Ribera; Gloria Serena; Jundi Liu; Alessio Fasano; Marcy A Kingsbury; Maria R Fiorentino
Journal:  Tissue Barriers       Date:  2021-11-14

Review 7.  Emerging concepts in non-invasive monitoring of Crohn's disease.

Authors:  Wojciech Marlicz; Karolina Skonieczna-Żydecka; Konstantinos John Dabos; Igor Łoniewski; Anastasios Koulaouzidis
Journal:  Therap Adv Gastroenterol       Date:  2018-04-18       Impact factor: 4.409

8.  Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model.

Authors:  Yen-Bo Su; Tzu-Hao Li; Chia-Chang Huang; Hung-Cheng Tsai; Shiang-Fen Huang; Yun-Cheng Hsieh; Ying-Ying Yang; Yi-Hsiang Huang; Ming-Chih Hou; Han-Chieh Lin
Journal:  PLoS One       Date:  2018-04-23       Impact factor: 3.240

9.  Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease.

Authors:  Sara Carbajo-Pescador; David Porras; María Victoria García-Mediavilla; Susana Martínez-Flórez; María Juarez-Fernández; María José Cuevas; José Luis Mauriz; Javier González-Gallego; Esther Nistal; Sonia Sánchez-Campos
Journal:  Dis Model Mech       Date:  2019-04-30       Impact factor: 5.758

10.  Disruption of gut integrity and permeability contributes to enteritis in a fish-parasite model: a story told from serum metabolomics.

Authors:  Ariadna Sitjà-Bobadilla; Rubén Gil-Solsona; Itziar Estensoro; M Carla Piazzon; Juan Antonio Martos-Sitcha; Amparo Picard-Sánchez; Juan Fuentes; Juan Vicente Sancho; Josep A Calduch-Giner; Félix Hernández; Jaume Pérez-Sánchez
Journal:  Parasit Vectors       Date:  2019-10-16       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.